Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like <b>UBM Medica</b>'s <b>Oncology And Society For Integrative Oncology (Sio)</b> Announce Partnership July 30, 2017 Provectus Announces Extension Of Rights Offering Due To Receipt Of Unsolicited Investment Proposals To Invest In March 5, 2017 Regulus Announces Pricing Of Public Offering Of Common Stock July 19, 2017
<b>UBM Medica</b>'s <b>Oncology And Society For Integrative Oncology (Sio)</b> Announce Partnership July 30, 2017
Provectus Announces Extension Of Rights Offering Due To Receipt Of Unsolicited Investment Proposals To Invest In March 5, 2017